Literature DB >> 15917294

DYRK1A enhances the mitogen-activated protein kinase cascade in PC12 cells by forming a complex with Ras, B-Raf, and MEK1.

Paul A Kelly1, Zohra Rahmani.   

Abstract

Dual-specificity tyrosine-phosphorylated and regulated kinase 1A (Dyrk1A) is the human homologue of the Drosophila mnb (minibrain) gene. In Drosophila, mnb is involved in postembryonic neurogenesis. In human, DYRK1A maps within the Down syndrome critical region of chromosome 21 and is overexpressed in Down syndrome embryonic brain. Despite its potential involvement in the neurobiological alterations observed in Down syndrome patients, the biological functions of the serine/threonine kinase DYRK1A have not been identified yet. Here, we report that DYRK1A overexpression potentiates nerve growth factor (NGF)-mediated PC12 neuronal differentiation by up-regulating the Ras/MAP kinase signaling pathway independently of its kinase activity. Furthermore, we show that DYRK1A prolongs the kinetics of ERK activation by interacting with Ras, B-Raf, and MEK1 to facilitate the formation of a Ras/B-Raf/MEK1 multiprotein complex. These data indicate that DYRK1A may play a critical role in Ras-dependent transducing signals that are required for promoting or maintaining neuronal differentiation and suggest that overexpression of DYRK1A may contribute to the neurological abnormalities observed in Down syndrome patients.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15917294      PMCID: PMC1182298          DOI: 10.1091/mbc.e04-12-1085

Source DB:  PubMed          Journal:  Mol Biol Cell        ISSN: 1059-1524            Impact factor:   4.138


  56 in total

Review 1.  Meaningful relationships: the regulation of the Ras/Raf/MEK/ERK pathway by protein interactions.

Authors:  W Kolch
Journal:  Biochem J       Date:  2000-10-15       Impact factor: 3.857

2.  A new expression cloning strategy for isolation of substrate-specific kinases by using phosphorylation site-specific antibody.

Authors:  R Matsuo; W Ochiai; K Nakashima; T Taga
Journal:  J Immunol Methods       Date:  2001-01-01       Impact factor: 2.303

3.  The protein kinase YakA regulates g-protein-linked signaling responses during growth and development of Dictyostelium.

Authors:  S van Es; K E Weening; P N Devreotes
Journal:  J Biol Chem       Date:  2001-06-15       Impact factor: 5.157

4.  The kinase DYRK phosphorylates protein-synthesis initiation factor eIF2Bepsilon at Ser539 and the microtubule-associated protein tau at Thr212: potential role for DYRK as a glycogen synthase kinase 3-priming kinase.

Authors:  Y L Woods; P Cohen; W Becker; R Jakes; M Goedert; X Wang; C G Proud
Journal:  Biochem J       Date:  2001-05-01       Impact factor: 3.857

5.  The kinase DYRK1A phosphorylates the transcription factor FKHR at Ser329 in vitro, a novel in vivo phosphorylation site.

Authors:  Y L Woods; G Rena; N Morrice; A Barthel; W Becker; S Guo; T G Unterman; P Cohen
Journal:  Biochem J       Date:  2001-05-01       Impact factor: 3.857

6.  Identification of B-KSR1, a novel brain-specific isoform of KSR1 that functions in neuronal signaling.

Authors:  J Müller; A M Cacace; W E Lyons; C B McGill; D K Morrison
Journal:  Mol Cell Biol       Date:  2000-08       Impact factor: 4.272

7.  Human minibrain homologue (MNBH/DYRK1): characterization, alternative splicing, differential tissue expression, and overexpression in Down syndrome.

Authors:  J Guimera; C Casas; X Estivill; M Pritchard
Journal:  Genomics       Date:  1999-05-01       Impact factor: 5.736

8.  The dominant negative Ras mutant, N17Ras, can inhibit signaling independently of blocking Ras activation.

Authors:  S Stewart; K L Guan
Journal:  J Biol Chem       Date:  2000-03-24       Impact factor: 5.157

9.  Regulation of Gli1 transcriptional activity in the nucleus by Dyrk1.

Authors:  Junhao Mao; Peter Maye; Priit Kogerman; Francisco J Tejedor; Rune Toftgard; Wei Xie; Guanqing Wu; Dianqing Wu
Journal:  J Biol Chem       Date:  2002-07-22       Impact factor: 5.157

10.  DYRK1 is a co-activator of FKHR (FOXO1a)-dependent glucose-6-phosphatase gene expression.

Authors:  Florian von Groote-Bidlingmaier; Dieter Schmoll; Hans Martin Orth; Hans Georg Joost; Walter Becker; Andreas Barthel
Journal:  Biochem Biophys Res Commun       Date:  2003-01-17       Impact factor: 3.575

View more
  33 in total

1.  DYRK1A autophosphorylation on serine residue 520 modulates its kinase activity via 14-3-3 binding.

Authors:  Mónica Alvarez; Xavier Altafaj; Sergi Aranda; Susana de la Luna
Journal:  Mol Biol Cell       Date:  2007-01-17       Impact factor: 4.138

2.  Nonprimed and DYRK1A-primed GSK3 beta-phosphorylation sites on MAP1B regulate microtubule dynamics in growing axons.

Authors:  Timothy M E Scales; Shen Lin; Michaela Kraus; Robert G Goold; Phillip R Gordon-Weeks
Journal:  J Cell Sci       Date:  2009-06-23       Impact factor: 5.285

3.  Transient expression of Mnb/Dyrk1a couples cell cycle exit and differentiation of neuronal precursors by inducing p27KIP1 expression and suppressing NOTCH signaling.

Authors:  Barbara Hämmerle; Edgar Ulin; Jordi Guimera; Walter Becker; François Guillemot; Francisco J Tejedor
Journal:  Development       Date:  2011-06       Impact factor: 6.868

4.  Splice variants of the dual specificity tyrosine phosphorylation-regulated kinase 4 (DYRK4) differ in their subcellular localization and catalytic activity.

Authors:  Chrisovalantis Papadopoulos; Krisztina Arato; Eva Lilienthal; Johannes Zerweck; Mike Schutkowski; Nicolas Chatain; Gerhard Müller-Newen; Walter Becker; Susana de la Luna
Journal:  J Biol Chem       Date:  2010-12-02       Impact factor: 5.157

5.  DYRK1A haploinsufficiency causes a new recognizable syndrome with microcephaly, intellectual disability, speech impairment, and distinct facies.

Authors:  Jianling Ji; Hane Lee; Bob Argiropoulos; Naghmeh Dorrani; John Mann; Julian A Martinez-Agosto; Natalia Gomez-Ospina; Natalie Gallant; Jonathan A Bernstein; Louanne Hudgins; Leah Slattery; Bertrand Isidor; Cédric Le Caignec; Albert David; Ewa Obersztyn; Barbara Wiśniowiecka-Kowalnik; Michelle Fox; Joshua L Deignan; Eric Vilain; Emily Hendricks; Margaret Horton Harr; Sarah E Noon; Jessi R Jackson; Alisha Wilkens; Ghayda Mirzaa; Noriko Salamon; Jeff Abramson; Elaine H Zackai; Ian Krantz; A Micheil Innes; Stanley F Nelson; Wayne W Grody; Fabiola Quintero-Rivera
Journal:  Eur J Hum Genet       Date:  2015-05-06       Impact factor: 4.246

6.  Genetic dissection of the Down syndrome critical region.

Authors:  Xiaoling Jiang; Chunhong Liu; Tao Yu; Li Zhang; Kai Meng; Zhuo Xing; Pavel V Belichenko; Alexander M Kleschevnikov; Annie Pao; Jennifer Peresie; Sarah Wie; William C Mobley; Y Eugene Yu
Journal:  Hum Mol Genet       Date:  2015-09-15       Impact factor: 6.150

Review 7.  Genetic and epigenetic pathways in Down syndrome: Insights to the brain and immune system from humans and mouse models.

Authors:  Y Eugene Yu; Zhuo Xing; Catherine Do; Annie Pao; Eun Joon Lee; Sharon Krinsky-McHale; Wayne Silverman; Nicole Schupf; Benjamin Tycko
Journal:  Prog Brain Res       Date:  2019-10-24       Impact factor: 2.453

8.  Human chromosome 21 orthologous region on mouse chromosome 17 is a major determinant of Down syndrome-related developmental cognitive deficits.

Authors:  Li Zhang; Kai Meng; Xiaoling Jiang; Chunhong Liu; Annie Pao; Pavel V Belichenko; Alexander M Kleschevnikov; Sheena Josselyn; Ping Liang; Ping Ye; William C Mobley; Y Eugene Yu
Journal:  Hum Mol Genet       Date:  2013-09-16       Impact factor: 6.150

Review 9.  A new fork for clinical application: targeting forkhead transcription factors in cancer.

Authors:  Jer-Yen Yang; Mien-Chie Hung
Journal:  Clin Cancer Res       Date:  2009-02-01       Impact factor: 12.531

10.  Sprouty2-mediated inhibition of fibroblast growth factor signaling is modulated by the protein kinase DYRK1A.

Authors:  Sergi Aranda; Mónica Alvarez; Silvia Turró; Ariadna Laguna; Susana de la Luna
Journal:  Mol Cell Biol       Date:  2008-08-04       Impact factor: 4.272

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.